# Commission Implementing Decision (EU) 2017/2201 of 27 November 2017 authorising the placing on the market of 2′-fucosyllactose produced with Escherichia coli strain BL21 as a novel food ingredient under Regulation (EC) No 258/97 of the European Parliament and of the Council (notified under document C(2017) 7662) (Only the German text is authentic), Annex I: SPECIFICATIONS OF 2′-FUCOSYLLACTOSE

Extent: E+W+S+N.I.

Definition:
Chemical name
α-L-fucopyranosyl-(1→2)-β-D-galactopyranosyl-(1→4)-D-glucopyranoside
Chemical formula
C18H32O15
Molecular mass
488,44 Da
CAS No.
41263-94-9
Description: 2′-fucosyllactose powder produced with a genetically modified strain of Escherichia coli BL21 is a white to ivory powder that is derived from 2′-fucosyllactose liquid concentrate by spray drying. The 2′-fucosyllactose liquid concentrate is a colourless to slight yellow clear 45 % w/v ± 5 % w/v aqueous solution.

---
Source: https://www.legislation.gov.uk/eudn/2017/2201/annex/I (the official version)
Page: https://openlegislation.uk/eu-decision-2017-2201/annex-I
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.